Shares of BioNTech Soar on a Coronavirus Vaccine Announcement [The Motley Fool]
BioNTech SE - American Depositary Shares (BNTX)
Company Research
Source: The Motley Fool
Maxx Chatsko(TMFBlackn)Author BioMaxx has been a contributor to Fool.com since 0. He graduated from the State University of New York College of Environmental Science and Forestry (0) with a Bachelor of Science in Bioprocess Engineering and from Carnegie Mellon University (06) with a Master of Science in Materials Science & Engineering.What happenedShares ofBioNTechNASDAQ:BNTXPfizerNYSE:PFEThe clinical trial will be the first of a coronavirus vaccine candidate to begin in Germany, although BioNTech and Pfizer expect to soon begin trials in the United States and China, too. As of 0: a.m. EDT on Wednesday, thepharma stockImage source: Getty Images.So whatThe German clinical trial will actually test four unique vaccine candidates. BioNTech designed each to trigger the body's production of antibodies thought to protect against the SARS-CoV- virus, which appears to attach to certain cells in the human body using high-affinity spike proteins.Two of the vaccine candidates target a long geneti
Show less
Read more
Impact Snapshot
Event Time:
BNTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BNTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BNTX alerts
High impacting BioNTech SE - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
BNTX
News
- Immuno-Oncology Investments Accelerate as Pipeline Catalysts Multiply in 2026PR Newswire
- BioNTech to Report Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on March 10, 2026GlobeNewswire
- BioNTech (NASDAQ:BNTX) was downgraded by analysts at Leerink Partners from an "outperform" rating to a "market perform" rating. They now have a $113.00 price target on the stock.MarketBeat
- Goldman Sachs Highlights BioNTech's (BNTX) Immuno-Oncology and ADC Pipeline [Yahoo! Finance]Yahoo! Finance
- BioNTech Announces Appointment of Kylie Jimenez to Management Board as Chief People OfficerGlobeNewswire
BNTX
Earnings
- 11/3/25 - Miss
BNTX
Sec Filings
- 2/12/26 - Form 144
- 1/28/26 - Form 6-K
- 1/14/26 - Form 6-K
- BNTX's page on the SEC website